close

Enter

Log in using OpenID

Botulinum Toxin Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
Botulinum toxin market is assessed to value over US$ 8 billion by the end of 2026 and to grow at a CAGR of over 7% during the forecast period of 2019-2026.
Botulinum Toxin Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
Botulinum toxin market is assessed to value over US$ 8 billion by the end of 2026
and to grow at a CAGR of over 7% during the forecast period of 2019-2026.
Botulinum toxin is supremely an essential way of preventing damage and
strengthening of dental hard tissues. Botulinum toxin type A (BOTOX) does not
involve the entrance of devices in the body and is generally utilized as a functional
mode of treatment of multiple healing symptoms. Botulinum toxin is a natural
protein produced by the anaerobic bacterium, Clostridium botulinum. Botulinum is
used for the treatment of strabismus and is desired in the cosmetic market. Growing
research activities expanded the scope of botulinum for the treatment of
neurological conditions like spasticity, dystonia, tremor, and others. Clinically
botulinum is used for the treatment of strabismus and huge demand in cosmetic
applications. Growing research activities expanded the scope of botulinum for the
treatment of neurological conditions like spasticity, dystonia, tremor, and others.
Along with this, recent research activities have concluded that botulinum is also
used for autonomic disorders like hypersecretory disorders, detrusor sphincter, and
others.
Easy and perennial acceptance of Botox products has fuelled the market of
botulinum toxin. FDA's approval for Dysport to treat lower leg in children has fuelled
the market. Also the FDA's approval for OnabotulinumtoxinA to be used as a
treatment for interim improvement in the emergence of moderate to severe
forehead lines blended with frontal muscle activities in adults has further expanded
the market.
The growing demand of botulinum in disease management led to the robust growth
of the market. The adding significance of botulinum in chemo-denervation has
generated huge demand among the general population. Also, the growing
importance of self-appearance and aesthetics in the middle of the general
population has fuelled the growth of the market. High spending capacity and huge
demand aesthetics among the general population of developed economies fuelled
the growth of the global market. However, the expensive treatment of botulinum
has restricted the growth of the market. Also, less knowledge of cosmetic products in
regions like Latin America and Rest of the World has hindered the potential of the
market. More preference for local products in such regions has restricted the growth
of the market.
Developed economies like North America and Europe account for more 60% of the
market share. The US dominated the North America market due to high penetration
among the general population and the end-user segment. UK, Germany, France, and
Italy dominated the European market. The Asia Pacific is the most opportunistic
market space for market players due to the limited presence of manufacturers. It
represented a fast-growing region during the forecast period. Latin America and Rest
of World is a highly untapped market due to the limited presence of manufacturers.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=184&page=requestsample
Botulinum Toxin Market Restraint
• Expensive treatment
• More preference for local products
• Less knowledge of cosmetic applications
Botulinum Toxin Market Segmentation
By Application
• Clinical Application
• Cosmetic Application
By End User
• Hospitals
• Cosmetic Centres
• Outpatient Centres
By Region
• North America
• Latin America
• Europe
• Asia and Pacific
• Rest of the World
Purchase a Copy of this Premium Research Report & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=184&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways
• Growth Aspects
• SWOT Analysis
• Key Trends
• Key data-points affecting key growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global botulinum toxin market by
application, by end user, by region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market.
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and
core competencies
Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global Botulinum Toxin A Market Overview
1.4.1.1. Global Botulinum Toxin Market Revenue (USD Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in Botulinum Toxin
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global Botulinum Toxin Market Revenue (USD Mn), 2018-2026 by
Application
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.7.1.4.1.1.
Clinical Application
1.7.1.4.1.2.
Cosmetic Application
1.8. Global Botulinum Toxin A Market Revenue (USD Mn), 2018-2026 by End
User
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.8.1.4.1.1.
Hospitals
1.8.1.4.1.2.
Cosmetic Centres
1.8.1.4.1.3.
Outpatient Centres
1.9. Global Botulinum Toxin Market Revenue (USD Mn), 2018-2026 by Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Region,2026
1.9.1.4.1.1.
North America
1.9.1.4.1.2.
Latin America
1.9.1.4.1.3.
Europe
1.9.1.4.1.4.
Asia Pacific
1.9.1.4.1.5.
Rest of world
1.10.
North America Botulinum Toxin A Market Revenue (US$ Mn), 20182026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.10.1.4.1.1.
US
1.10.1.4.1.2.
Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.10.1.5.1.1.
Clinical Application
1.10.1.5.1.2.
Cosmetic Application
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.10.1.6.1.1.
Hospitals
1.10.1.6.1.2.
Cosmetic Centres
1.10.1.6.1.3.
Outpatient Centres
1.11.
Latin America Botulinum Toxin Market Revenue (US$ Mn), 2018-2026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.11.1.4.1.1.
Brazil
1.11.1.4.1.2.
Mexico
1.11.1.4.1.3.
Argentina
1.11.1.4.1.4.
Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.11.1.5.1.1.
Clinical Application
1.11.1.5.1.2.
Cosmetic Application
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.11.1.6.1.1.
Hospitals
1.11.1.6.1.2.
Cosmetic Centres
1.11.1.6.1.3.
Outpatient Centres
1.12.
Europe America Botulinum Toxin Market Revenue (US$ Mn), 20182026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.12.1.4.1.1.
Germany
1.12.1.4.1.2.
France
1.12.1.4.1.3.
Spain
1.12.1.4.1.4.
UK
1.12.1.4.1.5.
Russia
1.12.1.4.1.6.
Poland
1.12.1.4.1.7.
Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.12.1.5.1.1.
Clinical Application
1.12.1.5.1.2.
Cosmetic Application
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.12.1.6.1.1.1.
Hospitals
1.12.1.6.1.1.2.
Cosmetic Centres
1.12.1.6.1.1.3.
Outpatient Centres
1.13.
Asia Pacific America Botulinum Toxin Market Revenue (US$ Mn),
2018-2026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.13.1.4.1.1.
Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2.
Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.13.1.5.1.1.
Clinical Application
1.13.1.5.1.2.
Cosmetic Application
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.13.1.6.1.1.
Hospitals
1.13.1.6.1.2.
Cosmetic Centres
1.13.1.6.1.3.
Outpatient Centres
1.14.
Rest of World America Botulinum Toxin Market Revenue (US$ Mn),
2018-2026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.14.1.4.1.1.
Middle East
1.14.1.4.1.2.
South Africa
1.14.1.4.1.3.
North Africa
1.14.1.4.1.4.
Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by
Application, 2018-2026
1.14.1.5.1.1.
Clinical Application
1.14.1.5.1.2.
Cosmetic Application
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.14.1.6.1.1.
Hospitals
1.14.1.6.1.2.
Cosmetic Centres
1.14.1.6.1.3.
Outpatient Centres
1.15.
Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1.
Merz Pharma GmbH & Co. KGaA
1.15.1.3.1.1.1.1. Corporate Overview
1.16.
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2.
Allergan Plc
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3.
Galderma
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.15.1.3.1.4.
Ipsen
1.15.1.3.1.4.1.1. Corporate Overview
1.15.1.3.1.4.1.2. Financial Performance
1.15.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.4.1.4. Company Strategy & Channel Management
1.15.1.3.1.5.
Pfizer Inc.
1.15.1.3.1.5.1.1. Corporate Overview
1.15.1.3.1.5.1.2. Financial Performance
1.15.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.5.1.4. Company Strategy & Channel Management
Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
2
File Size
21 KB
Tags
market
1/--pages
Report inappropriate content